ArticleJournal of hepatocellular carcinoma2020

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy.

Xuqi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.